News

Cromoz will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation

Kiadis Pharma (Kiadis) has reported the first patient enrollment in its multinational registration clinical trial with Atir. The study is designed to show reduction in Transplant Related Mortality

Spectrum Pharmaceuticals (Spectrum) has reported that one of the two Phase 3 pivotal clinical trials of Apaziquone has achieved its enrollment target, having enrolled approximately 800 patients with

Wedgewood Pharmacy is compounding Tiny Tabs in Megestrol Acetate 5mg and Famciclovir 31.25mg, in response to requests from veterinarians. Megestrol Acetate is commonly prescribed by veterinarians for behavioral-

Theravance has received a complete response letter from the FDA related to the telavancin New Drug Application (NDA) for the treatment of nosocomial pneumonia (NP). Telavancin is a

Ambrilia Biopharma has extended the license option agreement with ZBx that granted ZBx the worldwide rights to develop, manufacture and commercialise Ambrilia’s PSP94 technology in ZBx’s zap rapid

Lupin has reported that the FDA has started the inspection of its plant in Indore. After the company receives the approval from FDA, it is expected to initiate

Eli Lilly has received FDA approval for Cymbalta (duloxetine HCl) for the maintenance treatment of generalised anxiety disorder (GAD) in adults, The efficacy and safety of Cymbalta for

Lundbeck has initiated a multi-centre, placebo-controlled, fixeddose study of Lu AE58054 as add-on to donepezil in patients with moderate alzheimer’s disease. The clinical Phase II study is planned